Easom Eric (CIK 1914503) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-23). Recent activity: Buy ANTX (112,250 shares), Buy ANTX (10,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-23 | AN2 Therapeutics, Inc. (ANTX) | Chief Executive Officer | Buy | 112,250 | $0 |
| 2025-06-03 | AN2 Therapeutics, Inc. (ANTX) | Chief Executive Officer | Buy | 10,000 | $10,700 |
Source: SEC Form 4 filings · as of 2026-02-23